Ensure controls clearly indicate when they are selected
National Institute for Clincial Excellence
From: WCAG 2.2 AA 2.4.11
All controls on the page - including links, buttons, and fields - should clearly indicate when they have been selected by the keyboard.
Where this issue has occurred
| Title / URL | Issues |
|---|---|
Published guidance, NICE advice and quality standards | Guidance | NICEwww.nice.org.uk/guidance/published?sp=on | 5 |
Overview | Renal and ureteric stones: assessment and management | Guidance | NICEwww.nice.org.uk/guidance/NG118 | 3 |
Overview | Risankizumab for previously treated moderately to severely active Crohn's disease | Guidance | NICEwww.nice.org.uk/guidance/ta888 | 3 |
Overview | Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer | Guidance | NICEwww.nice.org.uk/guidance/ta898 | 3 |
Overview | Faricimab for treating diabetic macular oedema | Guidance | NICEwww.nice.org.uk/guidance/TA799 | 3 |
Overview | The PLASMA system for transurethral resection and haemostasis of the prostate | Guidance | NICEwww.nice.org.uk/guidance/MTG53 | 3 |
Overview | Delirium: prevention, diagnosis and management in hospital and long-term care | Guidance | NICEwww.nice.org.uk/guidance/CG103 | 3 |
Overview | AposHealth for knee osteoarthritis | Guidance | NICEwww.nice.org.uk/guidance/mtg76 | 3 |
Overview | Cardiovascular disease: risk assessment and reduction, including lipid modification | Guidance | NICEwww.nice.org.uk/guidance/ng238 | 3 |
Overview | Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management | Guidance | NICEwww.nice.org.uk/guidance/NG231 | 3 |
Only the top 10 issues are shown here